COPENHAGEN (Reuters) - Denmark's health authority said on Wednesday it expects to announce its decision on how to proceed with Johnson & Johnson's COVID-19 vaccine next week pending further investigations into its possible link to rare blood clots.
(Reporting by Nikolaj Skydsgaard; Editing by Andrew Heavens)
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!